LAS VEGAS, NV April 23, 2007 –
IMPAC Medical Systems, Inc. (IMPAC), an Elekta company and
leading provider of information technology (IT) solutions for
oncology care, launched its new unified cancer registry product,
METRIQ, at the 2007 IMPAC Cancer Registry Users Meeting. IMPAC
users from regional, state and national cancer registries can
now experience the benefits of IMPAC’s next generation cancer
registry integrated oncology data management system, including
workflow management and data analysis features and benefits.
The release of this unified cancer registry product results from
years of dedicated R&D to deliver a completely new visual
environment and infrastructure. METRIQ sets a new standard for
oncology information management by providing a fully-integrated
solution with an emphasis on multiple-vendor technology support.
METRIQ’s capabilities, demonstrated at IMPAC’s Cancer Registry
Users Meeting, include features that streamline the entire
cancer registry process from casefinding and abstracting to
reporting and data analysis.
“We are proud to announce the release of METRIQ, which we know
will establish a new dimension in cancer registry workflow
management,” stated James Hoey, President and CEO of IMPAC.
“What METRIQ users gain from this product release extends beyond
the basic cancer registry needs to provide a flexible system
that can be configured for the unique needs of cancer programs.
We’ve designed the framework to support full integration with
oncology data management systems so our customers can optimize
the information that they track for further outcomes analysis,
bridging today’s current needs with our future vision of cancer
registry data management.”
IMPAC will exhibit METRIQ cancer registry integrated oncology
data management system, at the National Cancer Registrars
Association (NCRA) Annual Meeting in Las Vegas, NV, April 23 -
25, 2007 and at the North American Association of Central Cancer
Registries (NAACCR) Annual Conference in Detroit, MI, June 2 -
9. You may visit IMPAC’s exhibit at NCRA (booth #24) and NAACCR;
and attend IMPAC’s presentation of “EMR Connectivity to
Registry” at NAACCR.
********
For more information, please contact:
Lorna Murdock, Marketing Communications Manager
IMPAC Medical Systems, Inc.
Tel: +1 408 830 8937, e-mail:
lmurdock@impac.com
Product
Inquiries:
Donna Getreuer, RN, MSN, CTR
Director Product Marketing, Decision Support
IMPAC Medical Systems, Inc.
Tel: +1 408-830-8000, e-mail:
dgetreuer@impac.com
Investor Enquiries:
Peter Ejemyr, Group VP Corporate Communications, Elekta AB
Tel: +46 733 611 000, e-mail:
peter.ejemyr@elekta.com
About IMPAC Medical Systems, Inc.
IMPAC Medical Systems, Inc., a company in the Elekta Group,
provides healthcare IT solutions that streamline clinical and
business operations across the spectrum of cancer care. IMPAC’s
open integration to multiple healthcare data and imaging systems
offers oncology-specific patient charting and practice
management, as well as best-of-breed systems for anatomic
pathology, clinical laboratory, and cancer registry. With
products that range from diagnosis and treatment through
long-term follow-up, IMPAC provides a comprehensive oncology
management solution that helps improve overall communication,
process efficiency, and quality patient care. For more
information about IMPAC’s products or services, please call
888-GO-IMPAC or visit
www.impac.com.
About
Elekta
Elekta is an international medical-technology Group, providing
meaningful clinical solutions, comprehensive information systems
and services for improved cancer care and management of brain
disorders. All of Elekta’s solutions employ non-invasive or
minimally invasive techniques and are therefore clinically
effective, gentle on the patient and cost-effective.
Clinical solutions include among others Leksell Gamma Knife® for
non-invasive treatment of brain disorders and Elekta Synergy®
for image guided radiation therapy (IGRT). Following the
acquisition of IMPAC Medical Systems Inc. in April 2005, the
Elekta Group is the world’s largest supplier of oncology
software. Elekta’s systems and solutions are used at over 4,000
hospitals around the world to treat cancer and manage clinical
operations as well as to diagnose and treat brain disorders,
including tumors, vascular malformations and functional
disorders. With approx. 2,000 employees, Elekta’s corporate
headquarter is located in Stockholm, Sweden and the company is
listed on the Stockholm Stock Exchange under the ticker EKTAb.
For more information about Elekta, please visit
www.elekta.com. |
|
Lorna Murdock
Marketing Communications Manager
IMPAC Medical Systems, Inc.
408-830-8937
pr@impac.com
Link Disclaimer
|
